MarketInOut Stock Screener Log In | Sign Up

Beryl Drugs Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:50
Beryl Drugs Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization125.22 mln
Float3.06 mln

EPS

1.55
Moderate

P / E

15.32
Moderately valued

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-3.13
Reliable

Relative Strength

34 / 100
Underperforming

Debt / Equity

0.25
Very low leverage

Business Description

Founded in 1993 and headquartered in Indore, India, Beryl Drugs Limited produces and sells a wide range of medicines across both human and animal health markets. Its product lineup includes branded and generic drugs, intravenous fluids, injectable solutions, and eye and ear drops. The company also takes on manufacturing work for other businesses and conducts ongoing research to develop new treatments. Beryl Drugs sells its products within India and to customers abroad.

Key Fundamentals

EPS1.55
P/E15.32
ROE6.50
RPS37.11
ROIC6.12
ROA3.86
Interest Cover3.58
EBITDA, mln25.22
EV / EBITDA5.77
EV / EBIT13.32
Revenue, mln220
EV / Revenue0.66

Quote Details

Last 23.75
Change -1.12 (-4.5%)
Open 25.37
Volume 223
Turnover 5,296.25
Average Volume 2,499.48

Financial Ratios

Pre-Tax Profit Margin4
Leverage Ratio1.51
Current Ratio1.52
Price / Book1.32
Price / Tangible Book1.32
Debt / Equity0.25
Price / Sales0.59
PEG Ratio1.19

Financial Strength

Altman Z-Score3.82
Piotroski F-Score 5 / 9
Beneish M-Score-3.13
Price to Lynch Fair Value1.27
Price to Graham Number1.34
Shiller PE Ratio20.80

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -4.54% 42 / 100   
1 Month -0.88% 76 / 100   
2 Months 6.98% 79 / 100   
6 Months 0.85% 64 / 100   
1 Year 1.06% 72 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog